DIALYSIS · CCN 212699

DaVita Glenarden Dialysis

LANHAM, MD 20706

DialysisProfitDaVita
$2.8M
TOTAL REVENUE
30.8%
OPERATING MARGIN
2 / 5
STAR RATING
12
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$2.8M
Total costs
$1.9M
Operating income (rev − costs)
$852K
Operating margin
30.8%
Total charges
$2.8M
Total treatments
5,159
Dialysis stations
24

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

12 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.2812—
Fistula Rate
DFC_FISTULA_RATE
53.246—
Five Star Rating
DFC_FIVE_STAR
2——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.4316—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
86.435—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
2346—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
21.9109—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
3.838—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
30.215—
Standardized ED Visits Ratio
DFC_SEDR
0.8420—